BOLALARDA ATOPIK DERMATITGA OLIB KELADIGAN XAVF OMILLARI
Keywords:
Atopik dermatit, psixosomatik omil, genetik determinantlar, retrospektiv tadqiqot, “AtopikDermabot”, SCORAD indeksi, ijtimoiy va psixologik omillar.Abstract
Pediatriyada allergik kasalliklar bilan kasallangan bolalar muammosi yetakchi o‘rinni egallaydi. Bu allergik kasalliklar orasida Atopik dermatit eng muhim o‘rinda turadi va dunyo bo‘ylab bolalar orasida eng keng tarqalgan surunkali teri kasalliklaridan biri hisoblanadi. Sababi shundaki hozirgi kunda bu kasallikning uzluksiz o‘sishi kuzatilmoqda. Barcha allergik kasalliklarni 40-60%ni allergik dermatozlar egallaydi (M.M.Fedotov, O.S.Fedlrova, U.V.Konovalova,2018). Rossiya davlatini rasmiy statistik ma‘lumotlariga ko‘ra har 100 ming aholini 240-250 nafarida allergik kasalliklar kuzatiladi. JSSTni ma‘lumotlariga ko‘ra AtD allergik kasalliklarning 12,9-32,3% gachani tashkil etgan (dfd.prof.Mavlyanova Sh.Z ma‘lumotlariga ko‘ra atopik dermatit O‘zbekistonda 37,1%ni tashkil etadi) .
References
1. Атопический дерматит: клинические рекомендации. — 2020. [Atopicheskii dermatit: Clinical guidelines.(InRuss).] Доступно по: https://nrcii.ru/specialistam/klinrecommend/atopic_dermatitis_2020.pdf. Ссылка активна на 24.09.2022.
2. Amano W, Nakajima S, Kunugi H, et al. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling. J Allergy Clin Immunol. 2015;136(3):667–677.e7. doi: https://doi.org/ 10.1016/j.jaci.2015.03.051
3. Wollenberg A, Ehmann LM. Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema. Ann Dermatol. 2012;24(3):253.doi: https://doi.org/10.5021/ad.2012.24.3.253
4. Amat F, Soria A, Tallon P, et al. New insights into the phenotypes of atopic dermatitis linked with allergies and asthma in children: An overview. Clin Exp Allergy. 2018;48(8):919–934. doi: https://doi.org/10.1111/cea.13156
5. Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682. doi: https://doi.org/10.1111/jdv.14891
6. Egawa G, Kabashima K. Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march. J Allergy Clin Immunol. 2016;138(2):350–358. doi: https://doi.org/10.1016/j.jaci.2016.06.002
7. Granato L. Modulator from fractions of vegetable unsaponifiables.Personal Care. 2012;09:69–72.
8. Mirraximova M. X. et al. Night of atopic dermatitis in children komorbid laboratory-immunological properties //IMRAS. – 2023. – Т. 6. – №. 6. – С. 301-306.
9. Kh M. M., Kurbanova D. R., Nishanbaeva N. Y. Identification of clinical and laboratory changes of the gastrointestinal tract in atopic dermatitis in children and improvement of the principles of diagnosis and treatment/ISSN 2181-712X.
10. Čepelak I, Dodig S, Pavić I. Filaggrin and atopic march.Biochem Med (Zagreb). 2019;29(2):214–227. doi: https://doi.org/10.11613/bm.2019.0205
11. Man MQ, Barish GD, Schmuth M, et al. Deficiency of PPARbeta/ delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J Invest Dermatol. 2008;128(2):370–377. doi: https://doi.org/10.1038/ sj.jid.5701026
12. Tominaga M, Takamori K. Itch and nerve fibers with special reference to atopic dermatitis: Therapeutic implications. J Dermatol. 2014;41(3):205–212. doi: https://doi.org/10.1111/ 1346-8138.12317
13. Kido-Nakahara M, Furue M, Ulzii D, Nakahara T. Itch in Atopic Dermatitis. Immunol Allergy Clin North Am. 2017;37(1):113–122. doi: https://doi.org/10.1016/j.iac.2016.08.007
14. Thyssen JP, Kezic S. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol. 2014;134(4):792–799. doi: https://doi.org/10.1016/j.jaci.2014.06.014
15. Dale BA, Presland RB, Lewis SP, et al. Transient Expression of Epidermal Filaggrin in Cultured Cells Causes Collapse of Interme diate Filament Networks with Alteration of Cell Shape and Nuclear Integrity.J Invest Dermatol. 1997;108(2):179–187. doi: https://doi.org/ 10.1111/1523-1747.ep12334205
16. Stout TE, McFarland T, Mitchell JC, et al. Recombinant filaggrin is in - ternalized and processed to correct filaggrin deficiency. J Invest Der ma tol. 2014;134(2):423–429. doi: https://doi.org/10.1038/jid.2013.284
17. Kim JH, Bae HC, Ko NY, et al. Thymic stromal lymphopoietin downregulates filaggrin expression by signal transducer and activator of transcription 3 (STAT3) and extracellular signal-regulated kinase (ERK) phosphorylation in keratinocytes. J Allergy Clin Immunol. 2015;136(1):205–208.e9. doi: https://doi.org/10.1016/j.jaci.2015.04.026
18. Pellerin L, Henry J, Hsu CY, et al. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. J Allergy Clin Immunol. 2013;131(4):1094–1102. doi: https://doi.org/10.1016/j.jaci.2012.12.1566
19. Nishanbayeva N. Y. Mirraximova MX Bolalarda atopik dermatitda oshqozon ichak traktidagi klinik laborator o ‘zgarishlarni aniqlash, tashxislash va davolash tamoyillarini takomillashtirish //Tibbiyotda yangi kun. – 2021. – Т. 6. – №. 38/1.
20. Mirrakhimova M. K. et al. Characteristics of Allergic Pathologies Progression in Young Children //American Journal of Medicine and Medical Sciences. – 2020. – Т. 10. – №. 9. – С. 652-656.
21. Mirrakhimova M. H., Nishanbaeva N. Y. Clinical Manifestations Of Connective Tissue Dysplasia In Children With Glomerulonephritis //Journal of Pharmaceutical Negative Results. – Т. 13. – С. 4203-4205.
